SECURE CLOUD ACCESS
LD PRODUCTS: EARLY DETECTION OF DIABETES COMPLICATIONS
Autonomic Nervous System and Vascular function Assessments
BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS
SCREENING OF RETINOPATHY
Monitoring and treatment.
Management of hypertension,
HEART RATE VARIABILITY (HRV)
Cardiac Autonomic Dysfunction Assessment.
PHOTOPLETHYSMOGRAPHY
CARDIAC AUTONOMIC REFLEX TESTs (CARTs)
Peripheral circulation and endothelial function Assessment
Cardiac Autonomic Neuropathy Assessment.
SUDOMOTOR
FUNCTION TESTS
ANKLE BRAKIAL INDEX (ABI)
Peripheral Artery Disease (PAD).
Blood flow blockage or calcification.
Small Fiber neuropathy Assessment.
Peripheral Autonomic and Microcirculatory Dysfunction Assessment
MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION
Fatigue
Headache
Dizziness
Exercise Intolerance
Fainting
Tingling in the Toes or Fingers
Claudication
Paintful muscle cramping in the hips, thighs or calves when walking, climbing stairs or exercising
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION IN THE USA
50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic)
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic)
70+
Population over 70 years old
OVER 45 MILLIONS PEOPLE
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH LD PRODUCTS